Venrock Healthcare Capital Partners Discloses 7.1% Stake in Biocryst Pharmaceuticals Inc (BCRX)

Page 14 of 19

Page 14 of 19 – SEC Filing
CUSIP No. 09058V103     Page 14 of 15
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct.
Dated: March 28, 2016
                         
Venrock Healthcare Capital Partners, L.P.
     
VHCP Co-Investment Holdings, LLC
         
By:
 
VHCP Management, LLC,
     
By:
 
VHCP Management, LLC,
     
   
its General Partner
 
its Manager
         
By:
 
/s/ David L. Stepp
     
By:
 
/s/ David L. Stepp
   
Name:
 
David L. Stepp
         
Name:
 
David L. Stepp
             
   
Title:
 
Authorized Signatory
         
Title:
 
Authorized Signatory
         
VHCP Management, LLC
               
           
By:
 
/s/ David L. Stepp
               
   
Name:
 
David L. Stepp
               
             
   
Title:
 
Authorized Signatory
               
         
/s/ David L. Stepp, as attorney-in-fact
               
         
Anders Hove
               
         
/s/ David L. Stepp, as attorney-in-fact
               
         
Bong Koh
               
                         
Venrock Healthcare Capital Partners II, L.P.
     
VHCP Co-Investment Holdings II, LLC
         
By:
 
VHCP Management II, LLC,
     
By:
 
VHCP Management II, LLC,
     
   
its General Partner
 
its Manager
         
By:
 
/s/ David L. Stepp
     
By:
 
/s/ David L. Stepp
   
Name:
 
David L. Stepp
         
Name:
 
David L. Stepp
             
   
Title:
 
Authorized Signatory
         
Title:
 
Authorized Signatory
         
VHCP Management II, LLC
               
           
By:
 
/s/ David L. Stepp
               
   
Name:
 
David L. Stepp
               
             
   
Title:
 
Authorized Signatory
               

Follow Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)

Page 14 of 19